284 related articles for article (PubMed ID: 30387820)
1. Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice.
Zhou H; Zhang HJ; Guan L; Zhang YN; Li Y; Sun MJ
Mol Med Rep; 2018 Dec; 18(6):5652-5662. PubMed ID: 30387820
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of Saccharomyces boulardii on intestinal mucosal barrier of dextran sodium sulfate-induced colitis in mice.
Dong JP; Zheng Y; Wu T; He Q; Teng GG; Wang HH
Chin Med J (Engl); 2019 Aug; 132(16):1951-1958. PubMed ID: 31335471
[TBL] [Abstract][Full Text] [Related]
3. Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Wang C; Li W; Wang H; Ma Y; Zhao X; Zhang X; Yang H; Qian J; Li J
BMC Microbiol; 2019 Nov; 19(1):246. PubMed ID: 31694526
[TBL] [Abstract][Full Text] [Related]
4. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition.
Rodríguez-Nogales A; Algieri F; Garrido-Mesa J; Vezza T; Utrilla MP; Chueca N; García F; Rodríguez-Cabezas ME; Gálvez J
J Nutr Biochem; 2018 Nov; 61():129-139. PubMed ID: 30236870
[TBL] [Abstract][Full Text] [Related]
5. Probiotic yeast inhibits VEGFR signaling and angiogenesis in intestinal inflammation.
Chen X; Yang G; Song JH; Xu H; Li D; Goldsmith J; Zeng H; Parsons-Wingerter PA; Reinecker HC; Kelly CP
PLoS One; 2013; 8(5):e64227. PubMed ID: 23675530
[TBL] [Abstract][Full Text] [Related]
6. Both
Xu X; Wu J; Jin Y; Huang K; Zhang Y; Liang Z
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986214
[TBL] [Abstract][Full Text] [Related]
7. Treatment of murine colitis by Saccharomyces boulardii secreting atrial natriuretic peptide.
Liu CH; Chang JH; Chang YC; Mou KY
J Mol Med (Berl); 2020 Dec; 98(12):1675-1687. PubMed ID: 33025105
[TBL] [Abstract][Full Text] [Related]
8. Saccharomyces boulardii decreases inflammation and intestinal colonization by Candida albicans in a mouse model of chemically-induced colitis.
Jawhara S; Poulain D
Med Mycol; 2007 Dec; 45(8):691-700. PubMed ID: 17885943
[TBL] [Abstract][Full Text] [Related]
9.
Gao H; Li Y; Sun J; Xu H; Wang M; Zuo X; Fu Q; Guo Y; Chen Z; Zhang P; Li X; Wang N; Ye T; Yao Y
Oxid Med Cell Longev; 2021; 2021():1622375. PubMed ID: 34367460
[No Abstract] [Full Text] [Related]
10.
Li B; Zhang H; Shi L; Li R; Luo Y; Deng Y; Li S; Li R; Liu Z
Food Funct; 2022 Jan; 13(1):102-112. PubMed ID: 34878454
[TBL] [Abstract][Full Text] [Related]
11. [Effect of VSL#3 and
Meng XC; Wang YN; Yan PG; Li YH; Wang HY; Qian JM; Li JN
Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(22):1735-1742. PubMed ID: 31216822
[No Abstract] [Full Text] [Related]
12. Faecalibacterium prausnitzii supernatant improves intestinal barrier function in mice DSS colitis.
Carlsson AH; Yakymenko O; Olivier I; Håkansson F; Postma E; Keita AV; Söderholm JD
Scand J Gastroenterol; 2013 Oct; 48(10):1136-44. PubMed ID: 23971882
[TBL] [Abstract][Full Text] [Related]
13. The Probiotic Effects of the
Lee JE; Lee E
J Microbiol Biotechnol; 2022 Jul; 32(7):877-884. PubMed ID: 35791078
[TBL] [Abstract][Full Text] [Related]
14. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
[TBL] [Abstract][Full Text] [Related]
15. Endothelial PAS domain protein 1 activates the inflammatory response in the intestinal epithelium to promote colitis in mice.
Xue X; Ramakrishnan S; Anderson E; Taylor M; Zimmermann EM; Spence JR; Huang S; Greenson JK; Shah YM
Gastroenterology; 2013 Oct; 145(4):831-41. PubMed ID: 23860500
[TBL] [Abstract][Full Text] [Related]
16. A new therapeutic association to manage relapsing experimental colitis: Doxycycline plus Saccharomyces boulardii.
Garrido-Mesa J; Algieri F; Rodriguez-Nogales A; Utrilla MP; Rodriguez-Cabezas ME; Zarzuelo A; Ocete MA; Garrido-Mesa N; Galvez J
Pharmacol Res; 2015 Jul; 97():48-63. PubMed ID: 25917208
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl peptidase-4 inhibitor anagliptin facilitates restoration of dextran sulfate sodium-induced colitis.
Mimura S; Ando T; Ishiguro K; Maeda O; Watanabe O; Ujihara M; Hirayama Y; Morise K; Maeda K; Matsushita M; Funasaka K; Nakamura M; Miyahara R; Ozaki N; Goto H
Scand J Gastroenterol; 2013 Oct; 48(10):1152-9. PubMed ID: 24047394
[TBL] [Abstract][Full Text] [Related]
18. Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.
Wu X; Vallance BA; Boyer L; Bergstrom KS; Walker J; Madsen K; O'Kusky JR; Buchan AM; Jacobson K
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G295-306. PubMed ID: 18032474
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of P-glycoprotein by probiotics in intestinal epithelial cells and in the dextran sulfate sodium model of colitis in mice.
Saksena S; Goyal S; Raheja G; Singh V; Akhtar M; Nazir TM; Alrefai WA; Gill RK; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G1115-23. PubMed ID: 21350189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
